Skip to main content

Find Clinical Trials

Home
Conditions
Kidney Cancer

Clinical trial condition

Kidney Cancer

Explore clinical trials studying Kidney Cancer. Study availability and eligibility vary by location and protocol.

356 public trials 59 recruiting studies

Refine in advanced search Browse all conditions

Kidney Cancer trial results

Completed

SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

NCT00006384

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States

USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

NCT00003091

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

Bloomington Hospital Bloomington, Indiana, United States

Baptist Regional Cancer Center - Knoxville Knoxville, Tennessee, United States

St. Joseph Regional Cancer Center Bryan, Texas, United States

View Trial Details

Completed

Dolastatin 10 in Treating Patients With Advanced Kidney Cancer

NCT00003914

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Biological Therapy in Treating Patients With Metastatic Cancer

NCT00002733

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

View Trial Details

Completed

Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer

NCT00278174

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases

NCT00006255

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer

NCT00003928

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

NCT00118326

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +56 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

NCT00010283

Conditions: Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

NCT00004157

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +94 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details